Cargando…

Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury

OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nipun, Tanzina Sharmin, Ema, Tanzila Ismail, Mia, Md. Abdur Rashid, Hossen, Md. Saddam, Arshe, Farzana Alam, Ahmed, Shahlaa Zernaz, Masud, Afsana, Taheya, Fatiha Faheem, Khan, Arysha Alif, Haque, Fauzia, Azad, Salauddin Al, Al Hasibuzzaman, Md., Tanbir, Mohammad, Anis, Samin, Akter, Sharmin, Mily, Sabrina Jahan, Dey, Dipta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757663/
https://www.ncbi.nlm.nih.gov/pubmed/35106293
http://dx.doi.org/10.5455/javar.2021.h544
_version_ 1784632724983644160
author Nipun, Tanzina Sharmin
Ema, Tanzila Ismail
Mia, Md. Abdur Rashid
Hossen, Md. Saddam
Arshe, Farzana Alam
Ahmed, Shahlaa Zernaz
Masud, Afsana
Taheya, Fatiha Faheem
Khan, Arysha Alif
Haque, Fauzia
Azad, Salauddin Al
Al Hasibuzzaman, Md.
Tanbir, Mohammad
Anis, Samin
Akter, Sharmin
Mily, Sabrina Jahan
Dey, Dipta
author_facet Nipun, Tanzina Sharmin
Ema, Tanzila Ismail
Mia, Md. Abdur Rashid
Hossen, Md. Saddam
Arshe, Farzana Alam
Ahmed, Shahlaa Zernaz
Masud, Afsana
Taheya, Fatiha Faheem
Khan, Arysha Alif
Haque, Fauzia
Azad, Salauddin Al
Al Hasibuzzaman, Md.
Tanbir, Mohammad
Anis, Samin
Akter, Sharmin
Mily, Sabrina Jahan
Dey, Dipta
author_sort Nipun, Tanzina Sharmin
collection PubMed
description OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the receptor’s active site properties and quantum tunneling. MATERIALS AND METHODS: A library of 120 phytochemical ligands was prepared, from which 5 were selected considering their absorption, distribution, metabolism, and excretion (ADMET) and quantitative structure–activity relationship (QSAR) profiles. The protein active sites and belonging quantum tunnels were defined to conduct supramolecular docking of the aforementioned ligands. The hydrogen bond formation and hydrophobic interactions between the ligand–receptor complexes were studied following the molecular docking steps. A comprehensive molecular dynamic simulation (MDS) was conducted for each of the ligand–receptor complexes to figure out the values – root mean square deviation (RMSD) (Å), root mean square fluctuation (RMSF) (Å), H-bonds, Cα, solvent accessible surface area (SASA) (Å(2)), molecular surface area (MolSA) (Å(2)), Rg (nm), and polar surface area (PSA) (Å). Finally, computational programming and algorithms were used to interpret the dynamic simulation outputs into their graphical quantitative forms. RESULTS: ADMET and QSAR profiles revealed that the most active candidates from the library to be used were apigenin, isovitexin, piperolactam A, and quercetin as test ligands, whereas serpentine as the control. Based on the binding affinities of supramolecular docking and the parameters of molecular dynamic simulation, the strength of the test ligands can be classified as isovitexin > quercetin > piperolactam A > apigenin when complexed with the hACE2 receptor. Surprisingly, serpentine showed lower affinity (−8.6 kcal/mol) than that of isovitexin (−9.9 kcal/mol) and quercetin (−8.9 kcal/mol). The MDS analysis revealed all ligands except isovitexin having a value lower than 2.5 Ǻ. All the test ligands exhibited acceptable fluctuation ranges of RMSD (Å), RMSF (Å), H-bonds, Cα, SASA (Å(2)), MolSA (Å(2)), Rg (nm), and PSA (Å) values. CONCLUSION: Considering each of the parameters of molecular optimization, docking, and dynamic simulation interventions, all of the test ligands can be suggested as potential targeted drugs in blocking the hACE2 receptor.
format Online
Article
Text
id pubmed-8757663
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET)
record_format MEDLINE/PubMed
spelling pubmed-87576632022-01-31 Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury Nipun, Tanzina Sharmin Ema, Tanzila Ismail Mia, Md. Abdur Rashid Hossen, Md. Saddam Arshe, Farzana Alam Ahmed, Shahlaa Zernaz Masud, Afsana Taheya, Fatiha Faheem Khan, Arysha Alif Haque, Fauzia Azad, Salauddin Al Al Hasibuzzaman, Md. Tanbir, Mohammad Anis, Samin Akter, Sharmin Mily, Sabrina Jahan Dey, Dipta J Adv Vet Anim Res Original Article OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the receptor’s active site properties and quantum tunneling. MATERIALS AND METHODS: A library of 120 phytochemical ligands was prepared, from which 5 were selected considering their absorption, distribution, metabolism, and excretion (ADMET) and quantitative structure–activity relationship (QSAR) profiles. The protein active sites and belonging quantum tunnels were defined to conduct supramolecular docking of the aforementioned ligands. The hydrogen bond formation and hydrophobic interactions between the ligand–receptor complexes were studied following the molecular docking steps. A comprehensive molecular dynamic simulation (MDS) was conducted for each of the ligand–receptor complexes to figure out the values – root mean square deviation (RMSD) (Å), root mean square fluctuation (RMSF) (Å), H-bonds, Cα, solvent accessible surface area (SASA) (Å(2)), molecular surface area (MolSA) (Å(2)), Rg (nm), and polar surface area (PSA) (Å). Finally, computational programming and algorithms were used to interpret the dynamic simulation outputs into their graphical quantitative forms. RESULTS: ADMET and QSAR profiles revealed that the most active candidates from the library to be used were apigenin, isovitexin, piperolactam A, and quercetin as test ligands, whereas serpentine as the control. Based on the binding affinities of supramolecular docking and the parameters of molecular dynamic simulation, the strength of the test ligands can be classified as isovitexin > quercetin > piperolactam A > apigenin when complexed with the hACE2 receptor. Surprisingly, serpentine showed lower affinity (−8.6 kcal/mol) than that of isovitexin (−9.9 kcal/mol) and quercetin (−8.9 kcal/mol). The MDS analysis revealed all ligands except isovitexin having a value lower than 2.5 Ǻ. All the test ligands exhibited acceptable fluctuation ranges of RMSD (Å), RMSF (Å), H-bonds, Cα, SASA (Å(2)), MolSA (Å(2)), Rg (nm), and PSA (Å) values. CONCLUSION: Considering each of the parameters of molecular optimization, docking, and dynamic simulation interventions, all of the test ligands can be suggested as potential targeted drugs in blocking the hACE2 receptor. A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) 2021-09-29 /pmc/articles/PMC8757663/ /pubmed/35106293 http://dx.doi.org/10.5455/javar.2021.h544 Text en Copyright: © Journal of Advanced Veterinary and Animal Research https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) )
spellingShingle Original Article
Nipun, Tanzina Sharmin
Ema, Tanzila Ismail
Mia, Md. Abdur Rashid
Hossen, Md. Saddam
Arshe, Farzana Alam
Ahmed, Shahlaa Zernaz
Masud, Afsana
Taheya, Fatiha Faheem
Khan, Arysha Alif
Haque, Fauzia
Azad, Salauddin Al
Al Hasibuzzaman, Md.
Tanbir, Mohammad
Anis, Samin
Akter, Sharmin
Mily, Sabrina Jahan
Dey, Dipta
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title_full Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title_fullStr Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title_full_unstemmed Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title_short Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
title_sort active site-specific quantum tunneling of hace2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing sars-cov-2 influx and subsequent cardiac injury
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757663/
https://www.ncbi.nlm.nih.gov/pubmed/35106293
http://dx.doi.org/10.5455/javar.2021.h544
work_keys_str_mv AT nipuntanzinasharmin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT ematanzilaismail activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT miamdabdurrashid activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT hossenmdsaddam activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT arshefarzanaalam activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT ahmedshahlaazernaz activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT masudafsana activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT taheyafatihafaheem activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT khanaryshaalif activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT haquefauzia activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT azadsalauddinal activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT alhasibuzzamanmd activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT tanbirmohammad activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT anissamin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT aktersharmin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT milysabrinajahan activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury
AT deydipta activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury